British Association for Pyschopharmacology. To advance education and research in the science of psychopharmacology
BAP Council is delighted to award Sue Iversen this prestigious award at the Summer Meeting in Cambridge.
Sue has long been one of the most influential psychopharmacologists in the non-clinical sphere in the U.K and internationally. Her c.v. shows that she has published over three hundred articles in peer-reviewed journals, the vast majority of which are relevant to psychopharmacology or neuropsychiatry. She was head of a pioneering laboratory in Cambridge that was one of the first to have combined psychopharmacology with neuropsychology and neurochemistry. This followed from the training experience she had with Larry Weiskrantz at Cambridge, Mortimer Mishkin at NIMH and Peter Dews at Harvard Medical School, which Sue combined so brilliantly to synthesise an innovative form of psychopharmacology. She has published as many as 15 papers in Nature and a half a dozen in Science on topics including the roles of the monoamines in behaviour, neural transplantation, neuropeptides such as CCK and substance P, and functional brain imaging relevant to schizophrenia. She has also co-edited the genuinely landmark series of The Handbook of Psychopharmacology and the excellent volume on Cognitive Neurochemistry, as well as producing a standard text in behavioural pharmacology and one of the excellent volumes in the BAP Monograph series. She was, for a decade, Director of Behavioural Pharmacology at Merck, Sharp and Dohme, before taking the Chair of Experimental Psychology at Oxford. She is now Pro-Vice Chancellor of the University.
Sue Iversen was, of course, also President of the British Association for Psychopharmacology, at a period (1984-86) critical for the future of the Association and helped lay the foundation for much of the success BAP has had since then. Her overall influence on the development of psychopharmacology in the UK has been immense, not only from her scientific contributions, but also the training of PhD students and post-doctoral workers who themselves have had considerable impact on the field. Some of these ‘Iversen products’ include, in rough chronological order, Ian Creese, Trevor Robbins, Arjun Sahgal, George Koob, Peter Kelly, Michael Petrides, Nick Tye, Barbara Sahakian, Ann Kelley, Eileen Joyce, Stephen Dunnett, Arlene Eison, John Salamone, Ron Mucha, Matthew Martin-Iverson, Nadia Rupniak, Colin Dourish, John Evenden, Gerry Dawson. Most of those named are either now professors or else high-ranking appointments in industry. Her collaborations have been even more extensive and have influenced our thinking about psychopharmacology from drug discovery to clinical practice.
Subscribe to the News Feed